Rice Hall James & Associates LLC bought a new position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 62,129 shares of the company’s stock, valued at approximately $989,000. Rice Hall James & Associates LLC owned about 0.14% of Avanos Medical as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of AVNS. Quarry LP bought a new stake in shares of Avanos Medical during the third quarter worth $42,000. KBC Group NV grew its stake in shares of Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after buying an additional 1,095 shares during the last quarter. Intech Investment Management LLC acquired a new position in shares of Avanos Medical during the third quarter worth $207,000. Atom Investors LP acquired a new position in shares of Avanos Medical during the third quarter worth $210,000. Finally, EP Wealth Advisors LLC acquired a new position in shares of Avanos Medical during the third quarter worth $212,000. Institutional investors own 95.17% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.
Avanos Medical Price Performance
Shares of NYSE:AVNS opened at $15.55 on Wednesday. The firm has a market cap of $714.63 million, a PE ratio of 45.73 and a beta of 0.98. The firm’s fifty day moving average is $16.45 and its 200-day moving average is $20.05. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical, Inc. has a 52 week low of $14.98 and a 52 week high of $25.36.
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Using the MarketBeat Stock Split Calculator
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- How to Invest in Blue Chip Stocks
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.